chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The symptoms began to occur on November 8, 2021.  Initially I thought maybe it was just the change in the weather, or seasonal allergies that was causing my skin to itch, but then it really blew up and the itching was uncontrollable and excruciating.  Also, I was experiencing trouble breathing randomly throughout the day and night.  I tried treating it at home with Benadryl and hyrdrocortisone cream, but the condition did not improve.  I called my doctor,  on November 10th and was prescribed Prednisone for three days.  I saw my dermatologist at local Dermatology office on November 12th as my condition was not improving.  My dermatologist prescribed Triamcinolone Acetonide cream and instructed me to take 2 doses of Zytec in the morning and 2 doses of Claritin in the evening.  I would need a gallon of the Triamcinolone Acetonide cream as my whole body was affected by the hives, blistering and irritation.  This seemed to make the itchiness subside somewhat, but when my skin did come into contact with something, it was still swelling and irritated and now I was getting nose bleeds due to being so dried out from the allergy medications.  I continued to have difficulty breathing from time to time.  I followed up with Dr.on November 30, 2021 as I was still having itchiness and my skin was still inflamed after coming into contact with anything.  I had blood drawn for allergy testing and those results are attached.  I was instructed to get chest x-rays and those results are attached as well.  I was prescribed another round of Prednisone, this time a heavier dosage that I completed over the following six days.  I was also prescribed Famotidine as the type-1 antihistamines were not solving the issues.  I was instructed to see an allergist and I saw a doctor from an allergy specialist office on December 6th.  More testing was performed, no major allergic reactions happened.  I was prescribed Singulair and an Albuterol Sulfate inhaler and told to use the inhaler as needed for my breathing difficulty.  I was also instructed to take a dose of Allegra along with the Famotidine in the morning and a dose of Zyrtec and Singulair in the evenings.  It is too early to tell if this treatment is making any progress.  As soon as my steroid prescription was completed, the itchiness returned.  I am still having trouble sleeping due to the itchiness and difficulty breathing.  I have followed every medical professional's prescribed regimen and I want my life to return to normal as it was before the Moderna Covid-19 booster.  My wife and I had our first child on September 27, 2021, and all of these issues that I have experienced since my Moderna Covid-19 booster shot have made my life a living hell and it has prevented me from being able to hold my child from time to time due to the severe pain of my skin.    I want to share this to get some answers.  I have suffered for a month now, and I have always been a healthy person and a quick healer.  I am going to follow up with the FDA as well.    Sincerely,
c/o itching 2 days p/vax;arm was sl swollen red;6 days later area around inj site red & extended down lateral area of arm;c/o itching & a tingling sensation in finger & hand;c/o c/o numbness on lt side of face, neck & shoulder;
dizziness, heavy headedness x 3 wks then neck & back pain, stiffness in muscles, arthralgia & myalgia w/sitting, standing & walking; unable to do any activity x 4 months; no tx or med relieves pain
sore arm at injection site only after 24 hours of the injection. Lasted a few days only.
I was fine at first. The next morning, I woke up with a bad pain in the joint of my left shoulder. I waited a few days before I contacted my doctor. By the third day, I contacted my doctor (via phone) and she told me to take aspirin, Tylenol or ibuprofen. I didn't have any pain at the injection site. It got better progressively over the next few days.
Info has been received from a physician concerning a pediatric pt who on 3/15/06 was vaccinated with a dose of rotavirus 01 02 03 F1 reassortant vaccine live (Human-bovine). The physician reported that on 3/15/06, the pt developed vomiting and lethargy. Unspecified medical attention was sought. Subsequently, the pt's vomiting and lethargy resolved. Additional info has been requested.
I had the booster on June 21, 2022, when I had peripheal nuropathy a few days later, I just thought it was anxiety as I was going through a stressful time with my husband?s eye cancer and our sons divorce.  Dr. put me on Lexapro, it went back a few weeks later as it was so painful and  it wasn?t working, she put me on Cymbalta, that worked better but still had low level pain. Went back again in the middle of August and she increased dosage. I finally got off it in September. I felt fine for about 5-6 weeks.  I had another booster on 10/13 as we were traveling. Eleven days later I was back in intense pain.  I didn?t connect it with the vaccine but then my son-in-law pointed out that some were having vaccine reactions that fit my symptoms.  My Dr put me on gabapentin.  I am getting better again but hoping to never get another vaccine. I had severe face/lip/limb pain, heat intolerance and breaking out in a sweat around my neck.  It was so bad I thought I needed to go to the ER but did not go.  It would come in waves, somedays better than others.  Shooting pain in different parts of my body and when it was bad and overall malaize that just was horrible.  I suffered!
On 2/5/00, the pt's family contacted the physicians office complaining of a rash and fever. Upon an exam at the physician's office, the pt was diagnosed with varicella. The pt had greater than 230 spots with a fever of 104. The pt was treated with ibuprofen and acetaminophen. ON 2/17/00, the pt recovered. No further information is available.
Case number PHEH2014US020691 is an initial spontaneous report received from a nurse on 10 OCT 2014. This report refers to a 50 year old female patient. Her past medical history and concomitant medications were not reported. On 08 OCT 2014, she was vaccinated with FLUCELVAX (batch number: 017021A) intramuscularly. On 08 OCT 2014, she developed a bumpy rash which started on her back, check and then spread down her arms. It was reported that there was nothing at the injection site. The outcome of the event was not reported. The seriousness and causality of the event was not reported.
Tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 (Lot number: BP7534) at the age of 50 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "not recovered", described as "Tiredness". The event "tiredness" was evaluated at the physician office visit.  Additional Information: Patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Apr2021, 16:00 (Lot number: unknown) as dose 2, single for covid-19 immunisation. Reaction reported was Extreme weight loss with onset Apr2021, Burning tongue, Nausea with outcome not recovered. Reporter states that the Caller was calling on behalf of his sister who got the second dose of the Pfizer Covid 19 vaccine, two months ago. The Caller provided his sister's age as 52, but later in Call, her age is confirmed as 50. Caller reports his sister had extreme weight loss, burning tongue, tiredness, and nausea. No additional Vaccines Administered on Same Date of the Pfizer Suspect. Prior Vaccinations (within 4 weeks) no other vaccinations within four weeks prior to the first administration date of the suspect vaccine.Caller stated that his "sister took the vaccine maybe 2 months ago (second dose), maybe 3-4 months ago, no actually 4 months ago". Pfizer Covid-19 vaccine (adult formulation) confirmed. Caller said that they've "notice significant changes like extreme weight loss, burning tongue. several, different, tired all kind of crazy stuffs that we think are related."  Follow-up attempts are completed. No further information is expected.
Received first and second dose one week or 6 days apart; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first and second dose one week or 6 days apart) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first and second dose one week or 6 days apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first and second dose one week or 6 days apart) had resolved.            No concomitant medications were reported No treatment medications were reported.  Symptoms: It was reported that the patient was in prison and he received the first dose of vaccine previous week and after 6 days or a week he received second dose of vaccine, and his third dose was schedule on 07-Oct-2021 which will be entered as second dose.
Patient received the wrong medication for his second dose of the Covid Vaccine. He should have had Moderna
Resting heart rate went from under 70 bpm to over 100 bpm. Body Aches. Chills. High Fever
Confirmed breakthrough case  COVID-19 (Pfizer) 1 04/01/2021 Pfizer ER8727   COVID-19 (Pfizer) 2 04/22/2021 Pfizer ER8733   COVID-19 (Pfizer-BNT 30mcg) 03/03/2022 Pfizer FJ6369
Sudden hearing loss, Right ear only. Ruled out physical blockage of external ear canal. No medical history for SHL. Onset was textbook: Overnight development, Acute onset, Nearly total hearing loss in R ear. Accompanied by minor tinnitus / low frequency.  No recent history of injury or illness.
4:30 pm cough, 7:30 chills, fever, seizures, swollen eyes, gue coming out of eyes, blurred vision whole body jerked for 12 hours.
Edema of entire thigh and mild erythema on opposite side of thigh to shot. Apparent tenderness but mild pain when patient ambulates and edema extending beyond knee or hip.
Pt was given Flublok instead of regular flu.  Health dept was called and was told there is no harm.  Pts mom was notified.
My arm got sore initially, it took a little time, an hour or two, then my arm started getting sore at the injection site. That Friday I was very tired, then on Tuesday 11/02/2021 I started getting indigestion in the morning. Then after I ate lunch I started vomiting, vomiting all night into the morning of Wednesday. The last two days I've been very tired and I'm not really sure if it has anything to do with the vaccine because it happened 5 days later. I'm just exhausted and I'm still fatigued. I did not go to work today and could barely take a shower. I had a virtual visit with my doctor yesterday 11/03/2021, they took blood today 11/04/2021. At first my doctor thought it was a bad case of acid reflux and just wasn't responding to the extra medications for that. He's referring me to GI since I had a bad episode similar to this one month ago. I didn't feel so bad a month ago because the next day I was bouncing back but I did also have vomiting.
Approx. 24 hours after vaccination, injection area began swelling, ultimately to the size of a large orange; erythema, pruritis, tenderness, very hard and lumpy.  Remained that way for four days.  Approximately one week later still itching minimally and area is slightly discolored.  Pharmacist wanted to report the Lot #: 1555X
Information has been received from an office manager concerning a 12 month old female who on 05-APR-2010 was vaccinated with a dose of MMR II (lot # 665801/1288Y) (route and site of administration not reported), and 10 days later (on 15-APR-2010) developed roseola. At the time of the report, the patient had not recovered from roseola. The patient sought medical attention by an office visit to the physician. This is one of several reports from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
PROQUAD was given instead of MMR along with the Varicella. Employee notified. Was also contacted by HD on 4/10/17. The same day I found the error when doing balancing. Employee stated that she originally pulled out the PROQUAD to give but was then informed that it was only patient's 1st doses and informed that individual doses of MMR and Varicella suppose to be given first to make sure no reaction noted.  Informed all staff members the importance of double checking all vaccines to be given with other employees.
pt recv vax 13AUG96 & 13AUG96 pt exp erythema & soreness @ inj site;pt missed 1 day of work & recovered by 15AUG96;
Information has been received from a physician concerning a 13 year old female patient with no pertinent medical history drug reactions or allergies who on 24-FEB-2011 was vaccinated IM with a third dose of GARDASIL (Lot# not reported). On 25-FEB-2011, 24 hours after vaccination, the patient developed fever and headache. The patient was diagnosed with malaria, a blood slide was positive for malaria on 28-FEB-2011. The patient was treated with "MALAFIN" and acetaminophen. On 01-MAR-2011, symptoms resolved. The event was not considered a serious adverse event, the patient only had outpatient investigations. Information has been received from a physician, author of the article. Adverse events were reported, there were 3 episodes of proven or presumptive malaria, one of which resulted in hospital admission. Additional information is not expected.
I went in for an mammogram in April and they called me back the next day and had me come in for a biopsy. The biopsy indicated that I had breast cancer and I went in in June and had a lumpectomy and 6 weeks after that I went in for 4 weeks of radiation for 5 days a week. I completed the radiation. I had a mammogram in December on the breast. I go back in June to have another one completed on both breast to determine if everything is ok. I had no genetic markers for cancer. I still have a lot of nerve pain from the radiation and the surgery. I also experienced severe burning from the radiation. I went to the doctor multiple times regarding that until it healed.
The patient called about 2 hrs after vaccination. She complained of soreness & pain at the site of injection going down to her arm. She will go to the doctor tomorrow & let us know.
"COVID" arm/"Moderna" arm.  Large round, bumpy, itchy rash below the injection site.   Took Benadryl till symptoms went away.  Rash disappeared within 4 days.
Pt recvd 3 doses of Engerix-B & reporter indicated that antibodies came back neg;
nose bled again and went to emergency room; her nose stared pouring blood; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (her nose stared pouring blood) and EPISTAXIS (nose bled again and went to emergency room) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LIOTHYRONINE, LEVOTHYROXINE, AMLODIPINE and LOSARTAN for an unknown indication.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021 at 8:00 AM, the patient experienced EPISTAXIS (her nose stared pouring blood). On 06-Nov-2021, the patient experienced EPISTAXIS (nose bled again and went to emergency room). On 05-Nov-2021, EPISTAXIS (her nose stared pouring blood) had resolved. At the time of the report, EPISTAXIS (nose bled again and went to emergency room) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Nov-2021, Blood Presuure: 195/114, 178/73 & 140/82. (abnormal) abnormal. On an unknown date, Computerised tomogram: negative Due to a fall she had prior doctors thought she hit her head but she said she never did..         No Treatment information was provided.  she states her blood pressure is usually controlled around 130/75.   This case was linked to MOD-2021-409286, MOD-2021-409280, MOD-2021-409286 (Patient Link).
Patient needed to receive Dtap and was given Tdap instead. The patient had no adverse reaction, and the state registry states the vaccine will count and does not need to be repeated.
Information has been received from a medical assistant referring to a multiple patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VARIVAX (lot# reported as L045956 with expiration date of 17-NOV-2017; strength dosage, frequency and route unspecified) (incorrect product storage). No adverse effect was reported. There was no previous temperature excursion. Temperature was 14.63 F with time frame of 4 minutes. Additional information has been requested.
pt presented with a swollen hand  joint at forefinger and middle finger was swollen and hot to touch and painful
Fever 101 degrees, night sweats (leading to dehydration), joint and muscle pain, nausea, vomiting, rash on chest/left arm, bruising on left arm, extreme pain and limited mobility on left arm, confusion, forgetfulness, dizziness, headache, extreme fatigue, increased heart rate - all symptoms lasting 7 days
Patient was under the age of 18 at the time of vaccination, no adverse events were reported for patient
Muscle and body aches, fatigue, headache, diarrhea, chills.
6-year-old patient received a first dose of Kinrix and today was not intended to receive any vaccines but due to a record error received a second dose of Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-year-old female patient who received DTPa-IPV (Kinrix) (batch number 34MF9, expiry date 13-FEB-2026) for prophylaxis.   On 24-OCT-2023, the patient received the 2nd dose of Kinrix. On 24-OCT-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 6-year-old patient received a first dose of Kinrix and today was not intended to receive any vaccines but due to a record error received a second dose of Kinrix). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 24-OCT-2023 The medical assistant called to report in March a 6-year-old patient received a first dose of Kinrix and today was not intended to receive any vaccines but due to a record error received a second dose of Kinrix. The vaccine administration facility was the same as primary reporter. Reporter stated patient was turning 7 years old on May 2024 and after error dose reported had a total of 2 doses of Dtap and IPV. The patient received Kinrix more than the age 6 years, which led to inappropriate age at vaccine administration. The reporter consented to follow up via email.
Swelling, Redness that went around whole arm, fever, and loss of range of motion temporarily. Patient contacted her PCP who prescribed her KEFLEX on day 3 and range of motion was back by day 4.
Hepatitis vaccine given + within one hour service member returned with the following symptoms: rash-red face & neck; c/o "ears on fire," "scratchy throat." No signs of SOB, wheezing, swelling, no reaction observed over injection site.
he got sick after the first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "he got sick after the first dose".  Additional information: The patient was due for the second dose on 17Mar2021 and mentioned he has a scheduled procedure 2 days after the second dose schedule; patient was querying if he can get the second dose or reschedule it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tested positive; tested positive; This is a spontaneous report received from contactable reporter (Pharmacist).  A 65-year-old male patient received BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Batch/Lot number: unknown), on 23Mar2021 as dose 2, single (Batch/Lot number: unknown) and on 23Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 08Jul2022, outcome "unknown" and all described as "tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to vaccination failure cannot be ruled out.
received partial dose of BOOSTRIX; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 21-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 43jh7, expiry date 23rd November 2023) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 11th March 2022, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 11th March 2022, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced underdose. On an unknown date, the outcome of the underdose was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that the patient received partial dose of Boostrix vaccine, which led to underdose. The patient did not receive 0.1ml dose of Boostrix. The reporter consented to follow up.
Pt devel fever by 3PM the day of vax started @ 101, towards evening fever was approaching 105; mom gave ASA & advil; awake most of first noc speaking incoherent @ times; mom stated delirious; Pt seen by MD o 14MAY92;
approx 1/2 hr p/3rd dose of vax pt exp an aching pain in lt side of neck, shoulder & arm; later that afternoon pt became nauseated, dizzy, lethargic & began a low grade fever, which lasted until 8PM;
Headaches , body and back ache, nausea, nausea started about 10 hrs after the second Pfizer covid vaccine dose , lasted almost 72 hrs.  Took tyelenol, zofran to help